Prohibits health benefit plans reviewing prescriptions for opioid addiction treatment.

Rhode Island Bill Summary: Opioid Addiction Treatment Prescriptions

This bill would prevent health insurance plans from requiring a review or approval process before covering prescription medications used to treat opioid addiction. Currently, many insurance plans use a process called "utilization review," where the insurer evaluates whether a prescribed treatment is necessary before agreeing to cover it. This bill would eliminate that step specifically for opioid addiction treatment medications, meaning insurers could not delay or deny coverage based on their own internal review of a doctor's prescription decision.

The people most directly affected are Rhode Islanders who struggle with opioid addiction and rely on prescription medications — such as buprenorphine or methadone — as part of their recovery treatment. Under current rules, patients sometimes face delays or denials from their insurance company even after a doctor has determined a medication is appropriate. This bill would require insurers to cover those prescriptions without that extra hurdle, potentially making it faster and easier for patients to access the treatment their doctor recommends.

Health insurance companies operating in Rhode Island would also be significantly affected, as they would lose the ability to conduct these reviews for this category of treatment. The bill is currently in the early stages of the legislative process, having been referred to the Senate Health and Human Services Committee, where it is awaiting further consideration.